cyc 202 has been researched along with dactinomycin in 2 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
979 | 7 | 393 | 19,045 | 355 | 969 |
Protein | Taxonomy | cyc 202 (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hernandez-Verdun, D; Roussel, P; Sirri, V | 1 |
2 other study(ies) available for cyc 202 and dactinomycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo release of mitotic silencing of ribosomal gene transcription does not give rise to precursor ribosomal RNA processing.
Topics: CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Colchicine; Dactinomycin; DNA-Directed RNA Polymerases; DNA, Ribosomal; Gene Silencing; HeLa Cells; Humans; Isoenzymes; Mitosis; Okadaic Acid; Phosphoproteins; Purines; RNA Processing, Post-Transcriptional; RNA, Ribosomal; Roscovitine; Transcription, Genetic | 2000 |